Journal article
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial
Abstract
BACKGROUND: In the Randomised Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial, dabigatran reduced occurrence of both stroke and haemorrhage compared with warfarin in patients who had atrial fibrillation and were at increased risk of stroke. We aimed to assess the effects of dabigatran compared with warfarin in the subgroup of patients with previous stroke or transient ischaemic attack.
METHODS: In the RE-LY trial, 18,113 patients …
Authors
Diener H-C; Connolly SJ; Ezekowitz MD; Wallentin L; Reilly PA; Yang S; Xavier D; Di Pasquale G; Yusuf S; group FTR-LS
Journal
The Lancet Neurology, Vol. 9, No. 12, pp. 1157–1163
Publisher
Elsevier
Publication Date
December 2010
DOI
10.1016/s1474-4422(10)70274-x
ISSN
1474-4422